E-Separation Solutions
Wednesday morning?s session, ?Achievements and Challenges in Mass Spectrometry,? was arranged by Imma Ferrer and Michael Thurman of the University of Colorado. Starting out the session will be Thurman with his opening remarks on the state of mass spectrometry.
Wednesday, March 3, 2010
Room 206A
Wednesday morning’s session, “Achievements and Challenges in Mass Spectrometry,” was arranged by Imma Ferrer and Michael Thurman of the University of Colorado. Starting out the session will be Thurman with his opening remarks on the state of mass spectrometry.
The first presentation will be given by Jennifer S. Brodbelt from the University of Texas. Brodbelt’s talk, “Photodissociation for Bioanalysis Mass Spectrometry,” will set an interesting tone for the rest of the session.
Following Brodbelt will be Jim Hager, of MDS Analytical Technologies, with “Recent Advances in Hybrid Linear Ion Trap Mass Spectrometry.” This 30-minute presentation will offer participants insight into the advances made in this area of mass spec.
Next up is session organizers Imma Ferrer and Michael Thurman with a presentation entitled, “Food Additives as Tracers of Wastewater Using Advanced Mass Spectrometry Techniques: The “Low Fat” Diet Impact.” Ferrer will lead the discussion and offer valuable information to the audience.
The next presentation will be given by Paul Zavitsanos and Bill Russ from Agilent Technologies. Their presentation, “The History and Development of the Triple Quadrupole Mass Spectrometer: State-of-the-Art and Future Developments,” will be an interesting take on the instrument side of mass spectrometry advances and challenges.
Finally, Nils Rehmann from the Research and Productivity Council will present, “Discovery of New Analogs of the Marine Biotoxin Azaspiracid in Blue Mussels (Mytilus edulis) by Ultra-performance Liquid Chromatography/tandem Mass Spectrometry.” This discussion will be approach the LC-MS aspect and offer new and exciting information to the audience.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.